BullFrog AI Announces Launch of BullFrog Data Networks™, a Data Insights Tool Powered by the bfLEAP™ Platform
September 20 2023 - 8:00AM
BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or
the "Company"), a technology-enabled drug development company using
artificial intelligence (AI) and machine learning to enable the
successful development of pharmaceuticals and biologics, today
announced the launch of BullFrog Data Networks, a
purpose-built, comprehensive data network platform that evaluates
high-dimension, multi-modal data in specific disease indications to
produce a customized, visual representation of previously unknown
relationships and pathways. The inaugural BullFrog Data Network
leverages a leading pan-cancer genomics dataset with over 10,000
primary cancer and normal samples including genomic,
transcriptomic, and proteomic data.
BullFrog Data Networks addresses the challenge
that many pharmaceutical and biotechnology companies face – a
wealth of data with limited resources for analysis. BullFrog Data
Networks provides a customizable data analysis solution that uses
machine learning to holistically evaluate data and reveals hidden
insights that cannot be achieved through manual data interrogation.
BullFrog Data Networks can be tailored to the needs of commercial
pharmaceutical and biotechnology companies and can process a wide
range of inputs, from publicly available information to proprietary
and exclusively licensed datasets. The customized data network can
be built in a short period, taking weeks rather than months,
starting from the identification of candidate data to the
presentation of answers to predefined queries. BullFrog Data
Networks will also be offered with value enhancing services
providing AI-powered analytics aimed at uncovering new therapeutic
targets and experimental pathways. The platform's explainable and
transparent insights are visualized in an intuitive format,
allowing users to examine individual nodes or clusters and
understand the relationships among them.
“Building networks is core to how we analyze
data. BullFrog Data Networks is an important component of BullFrog
AI’s revenue and growth strategy enabling successive sales of a
single data network,” said Vin Singh, Co-founder and CEO of
BullFrog AI. "BullFrog Data Networks aims to help accelerate and
improve drug development by building a complete visualization of
relationships gleaned from huge volumes of disease-specific ‘omics’
data, as well as multi-modal clinical data that can better inform
and materially transform approaches to investigating and
commercializing new drugs. We believe there is a significant market
opportunity for this solution.”
BullFrog Data Networks™ aim is to allow
stakeholders to derive novel insights toward target identification
and validation, understanding mechanism of action, clinical trial
optimization, drug repurposing, and more. Powered by the bfLEAP
platform, BullFrog Data Networks comes pre-loaded with answers to
central questions relevant to specific disease indications or
patient populations. It is designed to be used across the product
lifecycle, from target identification in early drug development to
prediction of treatment response and understanding safety and
tolerability of drug compounds. BullFrog Data Networks also has the
potential to help optimize clinical trials by better identifying
patient candidates and matching them to the right clinical trials
where they can receive potentially life-saving treatment more
quickly.
For more information and to request a demo,
please visit https://bullfrogai.com/solutions/data-networks/
About BullFrog AIBullFrog AI is
a technology-enabled drug development company that creates and
analyzes networks of biological, clinical, and real-world data
spanning from early discovery to late-stage clinical trials.
Through its partnerships with leading research institutions,
BullFrog AI is at the forefront of AI-driven drug development using
its proprietary bfLEAP™ artificial intelligence platform. BullFrog
AI is deploying bfLEAP™ for use at several critical stages of
development with the intention of streamlining data analytics in
therapeutics development, decreasing the overall development costs
by decreasing failure rates for new therapeutics.
For more information visit BullFrog AI atWebsite:
https://bullfrogai.com LinkedIn:
https://www.linkedin.com/company/bullfrogai/
Safe Harbor StatementThis press
release contains forward-looking statements. We base these
forward-looking statements on our expectations and projections
about future events, which we derive from the information currently
available to us. Such forward-looking statements relate to future
events or our future performance, including: our financial
performance and projections; our growth in revenue and earnings;
and our business prospects and opportunities. You can identify
forward-looking statements by those that are not historical in
nature, particularly those that use terminology such as "may,"
"should," "expects," "anticipates," "contemplates," "estimates,"
"believes," "plans," "projected," "predicts," "potential," or
"hopes" or the negative of these or similar terms. In evaluating
these forward-looking statements, you should consider various
factors, including: our ability to change the direction of the
Company; our ability to keep pace with new technology and changing
market needs; and the competitive environment of our business.
These and other factors may cause our actual results to differ
materially from any forward-looking statement. Forward-looking
statements are only predictions. The forward-looking events
discussed in this press release and other statements made from time
to time by us or our representatives, may not occur, and actual
events and results may differ materially and are subject to risks,
uncertainties, and assumptions about us. We are not obligated to
publicly update or revise any forward-looking statement, whether as
a result of uncertainties and assumptions, the forward-looking
events discussed in this press release and other statements made
from time to time by us or our representatives might not occur.
BFRG Contacts:InvestorsDave
GentryRedChip Companies, Inc.BFRG@redchip.com800-733-2447
MediaTiberend Strategic Advisors, Inc.Eric
Reissereiss@tiberend.com802-249-1136
Dave Schemeliadschemelia@tiberend.com609-468-9325
SOURCE: BullFrog AI Holdings,
Inc.
Bullfrog AI (NASDAQ:BFRGW)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bullfrog AI (NASDAQ:BFRGW)
Historical Stock Chart
From Jul 2023 to Jul 2024